Sir Professor Munir Pirmohamed
Clinical Pharmacologist, Geneticist and the NHS Chair of Pharmacogenetics, UK
About this event
- Date and time Tue 22 Jan 2019 from 8:30am to 23 Jan 2019 at 10:00pm
- Location Royal Society of Medicine
- Organised by Pathology, Pathological Society of Great Britain and Ireland
Welcome to the 2nd joint RSM and Pathological Society winter meeting!
This year's theme is “Let’s talk about Precision Pathology!”. During this two day meeting, delegates will be updated on the importance of precision pathology in a range of areas, including accurate diagnoses across a wide spectrum of neoplastic and non-neoplastic conditions, and subsequent patient treatment and management.
Delegates will get an insight into exciting emerging novel technologies that are already being used, and others that are soon to be incorporated into routine pathology. Experienced pathologists will look at how the resultant data from these technologies can be analysed via Computational Pathology, and incorporated into ‘real time’ and ‘real world’ systems.
Finally, delegates will hear about how innovative technologies (e.g. 3D printing and Virtual Reality) can be used to enhance pathology teaching and training at both undergraduate and postgraduate levels.
Topics include:
- The importance of ‘precision pathology’ in ‘personalised medicine’
- The increasing range of molecular tests being applied across neoplastic and non-neoplastic conditions, improving the precision of diagnosis and patient management
- The importance of equal access to molecular testing across the UK for both genders
- Emerging novel technologies that may soon be incorporated into routine pathology, and the new data interpretation opportunities these will provide
- Examples of novel methodologies of pathology training
Key speakers
Professor Joanne Martin
President of the Royal College of Pathologists, Professor of Pathology, Queen Mary University of London and Director of Academic Health Sciences, Barts Health NHS Trust
Professor Charles Eberhart
Director of Neuropathology and Ophthalmic Pathology at The Johns Hopkins Hospital, and Editor of the latest WHO CNS tumour volume, USA
Professor Anna-Dorothea Wagner
Specialist in Gender-based approaches to studying and treating disease, Lausanne University Hospital, Switzerland
Professor Christopher Griffiths
Director of the Manchester Centre for Dermatology Research, and Head of the Dermatology Theme of the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre, UK
Professor Katrin Kerl
Specialist in Precision Dermatopathology, University of Zurich, Switzerland
Dr Ian Frayling
Goudie Award Lecturer – “Seeing patterns - the value of studying hereditary cancer”, and Member of Council, International Society for Gastrointestinal Hereditary Tumours (InSiGHT), UK
Professor Paul McMenamin
Professor of Anatomy with novel ideas for teaching undergraduate science and medical students, and is renowned within 3D printing industry, Australia
Dr Keith Kaplan
Founder and Director of the Army Telepathology Program, USA
Professor Ann Blandford
Director of the UCL Institute for Digital Health, renowned within industry, UK
Agenda
Day 1
Registration, tea and coffee
Welcome and introduction
Professor Sarah E Coupland, University of Liverpool
Symposium: Precision pathology and its application in the “Day-to-Day”— Part one
Professor Sarah E Coupland and Professor R Huss
Precision medicine
Sir Professor Munir Pirmohamed, Chair of Medicine, David Weatherall and Chair of Pharmacogenetics, NHS
Precision pathology
Professor Jo Martin, President, Royal College of Pathologists, Professor of Pathology, Queen Mary University of London and Director of Academic Health Sciences, Barts Health NHS Trust
Open discussion
Refreshment break, trade exhibition and poster viewing
Plenary oral presentations
Professor Heike Grabsch, Maastricht University, Maastricht and Professor CS Herrington, University of Edinburgh, Edinburgh, UK and Editor-in-Chief, Journal of Pathology
PL1 - An innovative technology for breast cancer death prevention in the developing world: A global cancer care perspective
PL2 - Quantifying the clonal expansion of gastric intestinal metaplasia in vivo at single cell resolution
PL3 - Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common progenitor cell carrying TET2 mutations
PL4 - The Molecular landscape of Malignant Peripheral Nerve sSeath Tumour (MPNST)
PL5 - Relationship of BRAF mutation status with clinical and pathological features in primary and metastatic melanomas
Lunch and trade exhibition
Poster viewing and chairman’s rounds
Symposium: Precision pathology and its application in the “Day-to-Day”— Part two
Professor JE Martin, Barts and The London School of Medicine and Dentistry and Professor P van der Valk, Free University Medical Center, Amsterdam, NL
Personalised molecular neuropathology – challenges and opportunities
Professor Charles Eberhart, Director of Neuropathology and Ophthalmic Pathology, Johns Hopkins University School of Medicine
Sexual dimorphism in cancer biology and treatment – an oncologists’ view
Dr Anna Dorothea Wagner, Consultant Medical Oncology and Senior Lecturer, Department of Oncology/Medical Oncology, Lausanne University Hospital
Open discussion
Refreshment break, trade exhibition and poster viewing
Symposium: Precision pathology and its application in the “Day-to-Day”— Part three
Professor Adrienne Flanagan, University College London and Royal National Orthopaedic Hospital and Dr A Bateman, University Hospital Southampton
Personalised dermatology
Professor Christopher Griffiths, Professor of Dermatology, University of Manchester
Personalised dermatopathology
Professor Katrin Kerl, University of Zurich, Switzerland
Very early diagnosis of hepatocellular carcinoma: Serological approaches
Professor Philip Johnson, Chair of Translational Oncology, University of Liverpool
Open discussion
Announcement
The Journal of Pathology Jeremy Jass Prize for Research Excellence in Pathology in 2017
The Pathological Society of Great Britain and Ireland 14th Goudie Lecture
Seeing patterns: The value of studying hereditary cancer - Dr Ian Frayling, Institute of Medical Genetics, University Hospital of Wales, Cardiff, UK
Close of day one
Society dinner, for those who have pre booked
Bunga Bunga,167 Drury Lane, Covent Garden, London WC2B 5PG - Includes entertainment by Beats Boutique
Day 2
Registration, tea and coffee
Welcome and introduction
Dr Philip Macklin, University of Oxford
Symposium: Applying innovative technologies to pathology
Dr Philip Macklin, Oxford and Hasan Haidar, Maastricht and Mr H Haidar, University of Maastricht, Maastricht, NL
The use of 3D printed resources and virtual reality in medical and biomedical teaching
Professor Paul McMenamin, Director, Centre for Human Anatomy Education, Monash University
Advancing cancer diagnostics with deep learning
Dr Keith Kaplan, Pathologist, Publisher, Tissuepathology.com and CMO, Corista
Open discussion
Refreshment break, trade exhibition and poster viewing
Symposium: Applying innovative technologies to pathology
Dr Philip Macklin and Mr H Haidar
Molecular imaging: Imaging life’s complexity with precision pathology: Imaging MS at work
Professor Ron Heeren, Professor of Molecular Imaging and Director M4I, The Maastricht MultiModal Molecular Imaging Institute, Maastricht, The Netherlands
Liquid biopsies: Monitoring cancer and its genome with circulating tumour DNA
Dr Nitzan Rosenfeld, Senior Group Leader, Cancer Research UK Cambridge Institute, University of Cambridge
Open discussion
'Rapid-Fire' Oral Presentations
Professor Adrienne Flanagan and Dr R Poulsom, Scientific Editor, Journal of Pathology and Journal of Pathology: Clinical Research
Characterising the effects of extracellular annexin A1 on macrophage phenotype and epithelial cell function in lung adenocarcinoma
Using transcriptomics to define metastatic risk in uveal melanoma
Positive AKT expression is a predictive marker for tumour recurrence in epithelial ovarian cancer
Whole genome sequencing (WGS) in cancer: Why fresh frozen tissue provides the patient with improved genomic results
The preliminary results from the 100,000 genomes project: The genomic landscape of colorectal cancer
Lunch, trade exhibition and poster viewing
The future of pathology: Considerations for technology adoption and training
Professor Manuel Salto-Tellez, Professor and Chair of Molecular Pathology, Queen’s University Belfast
Digital health - it’s application now in medicine
Professor Ann Blandford, Director, Institute of Digital Health, University College London
Open discussion and closure of the symposium
Refreshment break, trade exhibition and poster viewing
Networking workshop: Career development and time management
Miss IC Kamps, University of Maastricht, Maastricht, NL and Miss S Lako, University of Maastricht, Maastricht, NL
A pathologist in industry - a Q&A
Dr Keith Kaplan
Time management
Dr Caroline Young, Wellcome Trust Research Training Fellow, University of Leeds
Location
Royal Society of Medicine, 1 Wimpole St,, Marylebone, London, London, W1G 0AE, United Kingdom